“Based on emerging trials data, scientific collaboration and the sharing of medical evidence with Dr. Andrew Hill— Senior Research Fellow at the University of Liverpool who was hired by UNITAID to provide research for the World Health Organization (WHO)—the FLCCC has updated its dosing strategy for ivermectin, a key component of our I-Mask+ Protocol,” said Dr. Pierre Kory, FLCCC President. “The changes impact dosing for early outpatient treatment and hospital treatment protocols. The dosing for prophylaxis remains the same.”

The updated protocols can be found HERE.

MEDIA: For more information, please email [email protected]